# Small RNA Landscape of Platelet Dust: Platelet-Derived Extracellular Vesicles from Patients with Non-Small-Cell Lung Cancer

**Authors:** Mafalda Antunes-Ferreira, Ilias Glogovitis, Diogo Fortunato, Silvia D’Ambrosi, Mariona Colom Saborit, Galina Yahubyan, Vesselin Baev, Michael Hackenberg, Natasa Zarovni, Thomas Wurdinger, Danijela Koppers-Lalic

PMC · DOI: 10.3390/ncrna11030038 · Non-Coding RNA · 2025-05-07

## TL;DR

This study explores small RNA profiles in platelet-derived extracellular vesicles from lung cancer patients, revealing distinct miRNA patterns that could aid cancer detection.

## Contribution

The study provides a novel characterization of small RNA signatures in platelet dust and extracellular vesicles from non-small-cell lung cancer patients.

## Key findings

- EVs from NSCLC patients showed enrichment of four miRNAs and depletion of ten miRNAs.
- Platelet dust (CD61-positive) exhibited nineteen enriched and nine depleted miRNAs in NSCLC patients.
- The findings suggest potential for improved cancer detection using specific vesicle subpopulations.

## Abstract

Background: Platelet-derived Extracellular Vesicles, or “Platelet Dust” (PD), are reported as the most-abundant extracellular vesicles in plasma. However, the PD molecular content, especially the small RNA profile, is still poorly characterized. This study aims to characterize PD and other extracellular vesicles (EVs) in patients with non-small-cell lung cancer (NSCLC), focusing on their small RNA signatures and diagnostic potential. Methods: The EVs were isolated directly from the plasma of healthy donors and patients with NSCLC using the surface markers CD9, CD63, CD81 (overall EVs), and CD61 (PD). Small RNA sequencing was then performed to comprehensively profile the miRNAs. Results: Our analysis revealed distinct small RNA profiles in the EVs and the PD from the patients with NSCLC. The EVs (CD9-, CD63-, and CD81-positive) showed the enrichment of four miRNAs and the depletion of ten miRNAs, while the PD (CD61-positive) exhibited a more complex profile, with nineteen miRNAs enriched and nine miRNAs depleted in the patients with NSCLC compared to those of the healthy controls. Conclusions: This exploratory study enhances our understanding of miRNA composition within different plasma vesicle populations, shedding light on the biology of plasma vesicles and their contents. Furthermore, utilizing an extracellular vesicle isolation method with potential clinical applicability offers the prospect of improved cancer characterization and detection by selecting the most informative subpopulation of plasma vesicles.

## Linked entities

- **Proteins:** CD9 (CD9 molecule), CD63 (CD63 molecule), CD81 (CD81 molecule), ITGB3 (integrin subunit beta 3)
- **Diseases:** non-small-cell lung cancer (MONDO:0005233)

## Full-text entities

- **Genes:** CD81 (CD81 molecule) [NCBI Gene 975] {aka CVID6, S5.7, TAPA1, TSPAN28}, CD9 (CD9 molecule) [NCBI Gene 928] {aka BTCC-1, DRAP-27, MIC3, MRP-1, TSPAN-29, TSPAN29}, CD63 (CD63 molecule) [NCBI Gene 967] {aka AD1, HOP-26, ME491, MLA1, OMA81H, Pltgp40}, ITGB3 (integrin subunit beta 3) [NCBI Gene 3690] {aka BDPLT16, BDPLT2, BDPLT24, CD61, FMAIT1, GP3A}
- **Diseases:** cancer (MESH:D009369), NSCLC (MESH:D002289)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12101397/full.md

## Figures

6 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12101397/full.md

## References

25 references — full list in the complete paper: https://tomesphere.com/paper/PMC12101397/full.md

---
Source: https://tomesphere.com/paper/PMC12101397